How food and ethnicity affect a new drug in healthy men
Treatments studied
This early-stage study tests an investigational drug called JPI-547 in healthy male volunteers. The goal is to see how food and ethnic background affect how the drug moves through the body and to check that it is safe. If you qualify, you'll help doctors understand this drug before it is tested in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man between 19 and 50 years old.
- Your weight is between 110 and 198 pounds (50–90 kg), and your body mass index (BMI) is in a normal range (18.5–29.9).
- You are of Korean, Caucasian, or Chinese background.
- You have no significant medical history that could affect the study, and you are not allergic to PARP inhibitors (a type of cancer drug).
- You are willing to avoid smoking, alcohol, caffeine, grapefruit, and certain medications during the study, and follow birth control requirements if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two investigational drugs in healthy adults to see how the body absorbs, breaks down, and eliminates them, and to check for any side effects. If you are a healthy adult, you may be able to help researchers understand these drugs better.
This study tests how eating food changes how your body absorbs a new experimental drug called VV913. Researchers will give you the drug with and without food to see if meals make a difference in how well it works.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This early-phase study tests a new drug in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.